nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelfinavir—SLCO1A2—epilepsy syndrome	0.166	0.459	CbGaD
Nelfinavir—ABCG2—epilepsy syndrome	0.0701	0.194	CbGaD
Nelfinavir—CYP2C19—epilepsy syndrome	0.0551	0.153	CbGaD
Nelfinavir—CYP2D6—epilepsy syndrome	0.0408	0.113	CbGaD
Nelfinavir—ABCB1—epilepsy syndrome	0.0292	0.0808	CbGaD
Nelfinavir—CYP2B6—Fosphenytoin—epilepsy syndrome	0.0122	0.0271	CbGbCtD
Nelfinavir—SLC22A1—Midazolam—epilepsy syndrome	0.0116	0.0257	CbGbCtD
Nelfinavir—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.011	0.0245	CbGbCtD
Nelfinavir—CYP2B6—Clobazam—epilepsy syndrome	0.0106	0.0235	CbGbCtD
Nelfinavir—CYP3A7-CYP3A51P—Carbamazepine—epilepsy syndrome	0.0092	0.0205	CbGbCtD
Nelfinavir—CYP3A7—Carbamazepine—epilepsy syndrome	0.0092	0.0205	CbGbCtD
Nelfinavir—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.00886	0.0197	CbGbCtD
Nelfinavir—CYP2B6—Carbamazepine—epilepsy syndrome	0.00876	0.0195	CbGbCtD
Nelfinavir—CYP3A7-CYP3A51P—Phenytoin—epilepsy syndrome	0.00825	0.0184	CbGbCtD
Nelfinavir—CYP3A7—Phenytoin—epilepsy syndrome	0.00825	0.0184	CbGbCtD
Nelfinavir—CYP2C19—Felbamate—epilepsy syndrome	0.00824	0.0183	CbGbCtD
Nelfinavir—CYP2C19—Trimethadione—epilepsy syndrome	0.00824	0.0183	CbGbCtD
Nelfinavir—CYP2B6—Primidone—epilepsy syndrome	0.00818	0.0182	CbGbCtD
Nelfinavir—CYP2B6—Phenytoin—epilepsy syndrome	0.00785	0.0175	CbGbCtD
Nelfinavir—ABCB1—Levetiracetam—epilepsy syndrome	0.00782	0.0174	CbGbCtD
Nelfinavir—CYP2C19—Fosphenytoin—epilepsy syndrome	0.00775	0.0172	CbGbCtD
Nelfinavir—CYP3A7—Phenobarbital—epilepsy syndrome	0.00735	0.0164	CbGbCtD
Nelfinavir—CYP3A7-CYP3A51P—Phenobarbital—epilepsy syndrome	0.00735	0.0164	CbGbCtD
Nelfinavir—CYP2B6—Propofol—epilepsy syndrome	0.00733	0.0163	CbGbCtD
Nelfinavir—CYP3A7-CYP3A51P—Midazolam—epilepsy syndrome	0.00725	0.0161	CbGbCtD
Nelfinavir—CYP3A7—Midazolam—epilepsy syndrome	0.00725	0.0161	CbGbCtD
Nelfinavir—CYP2B6—Phenobarbital—epilepsy syndrome	0.007	0.0156	CbGbCtD
Nelfinavir—CYP3A7—Diazepam—epilepsy syndrome	0.00697	0.0155	CbGbCtD
Nelfinavir—CYP3A7-CYP3A51P—Diazepam—epilepsy syndrome	0.00697	0.0155	CbGbCtD
Nelfinavir—CYP2B6—Midazolam—epilepsy syndrome	0.0069	0.0154	CbGbCtD
Nelfinavir—CYP3A5—Carbamazepine—epilepsy syndrome	0.0069	0.0154	CbGbCtD
Nelfinavir—CYP2C9—Trimethadione—epilepsy syndrome	0.00685	0.0152	CbGbCtD
Nelfinavir—CYP2C19—Clobazam—epilepsy syndrome	0.00672	0.015	CbGbCtD
Nelfinavir—CYP2B6—Diazepam—epilepsy syndrome	0.00664	0.0148	CbGbCtD
Nelfinavir—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00644	0.0143	CbGbCtD
Nelfinavir—CYP3A5—Phenytoin—epilepsy syndrome	0.00619	0.0138	CbGbCtD
Nelfinavir—CYP2C19—Carbamazepine—epilepsy syndrome	0.00556	0.0124	CbGbCtD
Nelfinavir—CYP3A5—Phenobarbital—epilepsy syndrome	0.00551	0.0123	CbGbCtD
Nelfinavir—CYP3A5—Midazolam—epilepsy syndrome	0.00544	0.0121	CbGbCtD
Nelfinavir—ABCB1—Clobazam—epilepsy syndrome	0.00542	0.0121	CbGbCtD
Nelfinavir—CYP2B6—Valproic Acid—epilepsy syndrome	0.00523	0.0116	CbGbCtD
Nelfinavir—CYP3A5—Diazepam—epilepsy syndrome	0.00523	0.0116	CbGbCtD
Nelfinavir—ABCB1—Lamotrigine—epilepsy syndrome	0.00522	0.0116	CbGbCtD
Nelfinavir—CYP2C19—Primidone—epilepsy syndrome	0.00519	0.0116	CbGbCtD
Nelfinavir—CYP1A2—Carbamazepine—epilepsy syndrome	0.00513	0.0114	CbGbCtD
Nelfinavir—CYP2C19—Phenytoin—epilepsy syndrome	0.00499	0.0111	CbGbCtD
Nelfinavir—CYP1A2—Primidone—epilepsy syndrome	0.00479	0.0107	CbGbCtD
Nelfinavir—CYP2C19—Propofol—epilepsy syndrome	0.00465	0.0104	CbGbCtD
Nelfinavir—CYP2C9—Carbamazepine—epilepsy syndrome	0.00463	0.0103	CbGbCtD
Nelfinavir—ABCB1—Carbamazepine—epilepsy syndrome	0.00449	0.01	CbGbCtD
Nelfinavir—CYP2C19—Phenobarbital—epilepsy syndrome	0.00445	0.0099	CbGbCtD
Nelfinavir—CYP2C9—Primidone—epilepsy syndrome	0.00432	0.00962	CbGbCtD
Nelfinavir—CYP1A2—Propofol—epilepsy syndrome	0.0043	0.00956	CbGbCtD
Nelfinavir—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00428	0.00954	CbGbCtD
Nelfinavir—CYP2C19—Diazepam—epilepsy syndrome	0.00422	0.00939	CbGbCtD
Nelfinavir—CYP2C9—Phenytoin—epilepsy syndrome	0.00415	0.00924	CbGbCtD
Nelfinavir—CYP3A5—Valproic Acid—epilepsy syndrome	0.00412	0.00918	CbGbCtD
Nelfinavir—CYP2C19—Zonisamide—epilepsy syndrome	0.00412	0.00916	CbGbCtD
Nelfinavir—CYP1A2—Phenobarbital—epilepsy syndrome	0.0041	0.00914	CbGbCtD
Nelfinavir—ABCB1—Phenytoin—epilepsy syndrome	0.00403	0.00897	CbGbCtD
Nelfinavir—CYP3A4—Felbamate—epilepsy syndrome	0.00398	0.00887	CbGbCtD
Nelfinavir—CYP3A4—Trimethadione—epilepsy syndrome	0.00398	0.00887	CbGbCtD
Nelfinavir—CYP1A2—Diazepam—epilepsy syndrome	0.00389	0.00866	CbGbCtD
Nelfinavir—CYP2C9—Propofol—epilepsy syndrome	0.00387	0.00862	CbGbCtD
Nelfinavir—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00374	0.00834	CbGbCtD
Nelfinavir—CYP2C9—Phenobarbital—epilepsy syndrome	0.0037	0.00823	CbGbCtD
Nelfinavir—ABCB1—Phenobarbital—epilepsy syndrome	0.00359	0.00799	CbGbCtD
Nelfinavir—ABCB1—Midazolam—epilepsy syndrome	0.00354	0.00788	CbGbCtD
Nelfinavir—CYP2D6—Propofol—epilepsy syndrome	0.00354	0.00788	CbGbCtD
Nelfinavir—CYP2C9—Diazepam—epilepsy syndrome	0.00351	0.00781	CbGbCtD
Nelfinavir—ABCB1—Diazepam—epilepsy syndrome	0.0034	0.00757	CbGbCtD
Nelfinavir—CYP3A4—Clonazepam—epilepsy syndrome	0.00339	0.00754	CbGbCtD
Nelfinavir—CYP2C19—Valproic Acid—epilepsy syndrome	0.00332	0.0074	CbGbCtD
Nelfinavir—CYP3A4—Clobazam—epilepsy syndrome	0.00325	0.00723	CbGbCtD
Nelfinavir—CYP1A2—Valproic Acid—epilepsy syndrome	0.00307	0.00683	CbGbCtD
Nelfinavir—CYP2C19—Topiramate—epilepsy syndrome	0.003	0.00668	CbGbCtD
Nelfinavir—CYP2C9—Valproic Acid—epilepsy syndrome	0.00276	0.00615	CbGbCtD
Nelfinavir—CYP3A4—Rufinamide—epilepsy syndrome	0.00276	0.00615	CbGbCtD
Nelfinavir—CYP3A4—Carbamazepine—epilepsy syndrome	0.00269	0.00599	CbGbCtD
Nelfinavir—CYP3A4—Primidone—epilepsy syndrome	0.00251	0.00559	CbGbCtD
Nelfinavir—CYP3A4—Phenytoin—epilepsy syndrome	0.00241	0.00537	CbGbCtD
Nelfinavir—CYP3A4—Propofol—epilepsy syndrome	0.00225	0.00501	CbGbCtD
Nelfinavir—CYP3A4—Phenobarbital—epilepsy syndrome	0.00215	0.00479	CbGbCtD
Nelfinavir—CYP3A4—Acetazolamide—epilepsy syndrome	0.00215	0.00479	CbGbCtD
Nelfinavir—CYP3A4—Midazolam—epilepsy syndrome	0.00212	0.00472	CbGbCtD
Nelfinavir—CYP3A4—Diazepam—epilepsy syndrome	0.00204	0.00454	CbGbCtD
Nelfinavir—CYP3A4—Zonisamide—epilepsy syndrome	0.00199	0.00443	CbGbCtD
Nelfinavir—CYP3A4—Valproic Acid—epilepsy syndrome	0.00161	0.00358	CbGbCtD
Nelfinavir—CYP3A4—Topiramate—epilepsy syndrome	0.00145	0.00323	CbGbCtD
Nelfinavir—Indinavir—SLCO1A2—epilepsy syndrome	0.000563	0.169	CrCbGaD
Nelfinavir—Mitiglinide—KCNJ11—epilepsy syndrome	0.000506	0.152	CrCbGaD
Nelfinavir—Saquinavir—SLCO1A2—epilepsy syndrome	0.00042	0.126	CrCbGaD
Nelfinavir—Saquinavir—CYP11A1—epilepsy syndrome	0.000366	0.11	CrCbGaD
Nelfinavir—Indinavir—ABCC2—epilepsy syndrome	0.000269	0.081	CrCbGaD
Nelfinavir—Saquinavir—ABCC2—epilepsy syndrome	0.000201	0.0605	CrCbGaD
Nelfinavir—Indinavir—CYP2C19—epilepsy syndrome	0.000187	0.0563	CrCbGaD
Nelfinavir—Saquinavir—ABCG2—epilepsy syndrome	0.000178	0.0535	CrCbGaD
Nelfinavir—Saquinavir—CYP2C19—epilepsy syndrome	0.00014	0.042	CrCbGaD
Nelfinavir—Indinavir—CYP2D6—epilepsy syndrome	0.000139	0.0417	CrCbGaD
Nelfinavir—SLC22A1—ganglion—epilepsy syndrome	0.000107	0.107	CbGeAlD
Nelfinavir—Saquinavir—CYP2D6—epilepsy syndrome	0.000104	0.0312	CrCbGaD
Nelfinavir—Indinavir—ABCB1—epilepsy syndrome	9.91e-05	0.0298	CrCbGaD
Nelfinavir—Saquinavir—ALB—epilepsy syndrome	7.75e-05	0.0233	CrCbGaD
Nelfinavir—Saquinavir—ABCB1—epilepsy syndrome	7.4e-05	0.0223	CrCbGaD
Nelfinavir—Dizziness—Vigabatrin—epilepsy syndrome	5.11e-05	0.000379	CcSEcCtD
Nelfinavir—Pruritus—Zonisamide—epilepsy syndrome	5.1e-05	0.000378	CcSEcCtD
Nelfinavir—Hypersensitivity—Phenytoin—epilepsy syndrome	5.09e-05	0.000377	CcSEcCtD
Nelfinavir—Flatulence—Gabapentin—epilepsy syndrome	5.07e-05	0.000375	CcSEcCtD
Nelfinavir—Oedema—Valproic Acid—epilepsy syndrome	5.06e-05	0.000375	CcSEcCtD
Nelfinavir—Urticaria—Lamotrigine—epilepsy syndrome	5.06e-05	0.000375	CcSEcCtD
Nelfinavir—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	5.06e-05	0.000375	CcSEcCtD
Nelfinavir—Malaise—Pregabalin—epilepsy syndrome	5.06e-05	0.000375	CcSEcCtD
Nelfinavir—Nausea—Propofol—epilepsy syndrome	5.05e-05	0.000375	CcSEcCtD
Nelfinavir—Vomiting—Fosphenytoin—epilepsy syndrome	5.04e-05	0.000374	CcSEcCtD
Nelfinavir—Diarrhoea—Felbamate—epilepsy syndrome	5.04e-05	0.000374	CcSEcCtD
Nelfinavir—Body temperature increased—Lamotrigine—epilepsy syndrome	5.04e-05	0.000373	CcSEcCtD
Nelfinavir—Abdominal pain—Lamotrigine—epilepsy syndrome	5.04e-05	0.000373	CcSEcCtD
Nelfinavir—Dizziness—Diazepam—epilepsy syndrome	5.03e-05	0.000373	CcSEcCtD
Nelfinavir—Leukopenia—Pregabalin—epilepsy syndrome	5.02e-05	0.000372	CcSEcCtD
Nelfinavir—Rash—Fosphenytoin—epilepsy syndrome	5e-05	0.000371	CcSEcCtD
Nelfinavir—Dermatitis—Fosphenytoin—epilepsy syndrome	5e-05	0.00037	CcSEcCtD
Nelfinavir—Haemoglobin—Topiramate—epilepsy syndrome	4.99e-05	0.00037	CcSEcCtD
Nelfinavir—Asthenia—Clonazepam—epilepsy syndrome	4.99e-05	0.00037	CcSEcCtD
Nelfinavir—Rhinitis—Topiramate—epilepsy syndrome	4.98e-05	0.000369	CcSEcCtD
Nelfinavir—Back pain—Gabapentin—epilepsy syndrome	4.97e-05	0.000369	CcSEcCtD
Nelfinavir—Headache—Fosphenytoin—epilepsy syndrome	4.97e-05	0.000368	CcSEcCtD
Nelfinavir—Haemorrhage—Topiramate—epilepsy syndrome	4.97e-05	0.000368	CcSEcCtD
Nelfinavir—Hepatitis—Topiramate—epilepsy syndrome	4.97e-05	0.000368	CcSEcCtD
Nelfinavir—Thrombocytopenia—Valproic Acid—epilepsy syndrome	4.96e-05	0.000367	CcSEcCtD
Nelfinavir—Asthenia—Phenytoin—epilepsy syndrome	4.95e-05	0.000367	CcSEcCtD
Nelfinavir—Nausea—Midazolam—epilepsy syndrome	4.94e-05	0.000366	CcSEcCtD
Nelfinavir—Muscle spasms—Gabapentin—epilepsy syndrome	4.94e-05	0.000366	CcSEcCtD
Nelfinavir—Diarrhoea—Zonisamide—epilepsy syndrome	4.94e-05	0.000366	CcSEcCtD
Nelfinavir—Pharyngitis—Topiramate—epilepsy syndrome	4.93e-05	0.000365	CcSEcCtD
Nelfinavir—Asthenia—Oxcarbazepine—epilepsy syndrome	4.93e-05	0.000365	CcSEcCtD
Nelfinavir—Pruritus—Clonazepam—epilepsy syndrome	4.92e-05	0.000364	CcSEcCtD
Nelfinavir—Vomiting—Vigabatrin—epilepsy syndrome	4.92e-05	0.000364	CcSEcCtD
Nelfinavir—Skin disorder—Valproic Acid—epilepsy syndrome	4.92e-05	0.000364	CcSEcCtD
Nelfinavir—Hyperhidrosis—Valproic Acid—epilepsy syndrome	4.89e-05	0.000363	CcSEcCtD
Nelfinavir—Pruritus—Phenytoin—epilepsy syndrome	4.89e-05	0.000362	CcSEcCtD
Nelfinavir—Connective tissue disorder—Topiramate—epilepsy syndrome	4.88e-05	0.000362	CcSEcCtD
Nelfinavir—Nausea—Levetiracetam—epilepsy syndrome	4.88e-05	0.000362	CcSEcCtD
Nelfinavir—Rash—Vigabatrin—epilepsy syndrome	4.88e-05	0.000361	CcSEcCtD
Nelfinavir—Dizziness—Felbamate—epilepsy syndrome	4.87e-05	0.000361	CcSEcCtD
Nelfinavir—Dermatitis—Vigabatrin—epilepsy syndrome	4.87e-05	0.000361	CcSEcCtD
Nelfinavir—Pruritus—Oxcarbazepine—epilepsy syndrome	4.86e-05	0.00036	CcSEcCtD
Nelfinavir—Convulsion—Pregabalin—epilepsy syndrome	4.86e-05	0.00036	CcSEcCtD
Nelfinavir—Hypersensitivity—Carbamazepine—epilepsy syndrome	4.86e-05	0.00036	CcSEcCtD
Nelfinavir—Headache—Vigabatrin—epilepsy syndrome	4.85e-05	0.000359	CcSEcCtD
Nelfinavir—Vomiting—Diazepam—epilepsy syndrome	4.84e-05	0.000359	CcSEcCtD
Nelfinavir—Anorexia—Valproic Acid—epilepsy syndrome	4.83e-05	0.000358	CcSEcCtD
Nelfinavir—Rash—Diazepam—epilepsy syndrome	4.8e-05	0.000356	CcSEcCtD
Nelfinavir—Dermatitis—Diazepam—epilepsy syndrome	4.8e-05	0.000355	CcSEcCtD
Nelfinavir—Myalgia—Pregabalin—epilepsy syndrome	4.77e-05	0.000354	CcSEcCtD
Nelfinavir—Arthralgia—Pregabalin—epilepsy syndrome	4.77e-05	0.000354	CcSEcCtD
Nelfinavir—Ill-defined disorder—Gabapentin—epilepsy syndrome	4.77e-05	0.000354	CcSEcCtD
Nelfinavir—Dizziness—Zonisamide—epilepsy syndrome	4.77e-05	0.000353	CcSEcCtD
Nelfinavir—Headache—Diazepam—epilepsy syndrome	4.77e-05	0.000353	CcSEcCtD
Nelfinavir—Anxiety—Pregabalin—epilepsy syndrome	4.76e-05	0.000353	CcSEcCtD
Nelfinavir—Diarrhoea—Clonazepam—epilepsy syndrome	4.76e-05	0.000352	CcSEcCtD
Nelfinavir—Anaemia—Gabapentin—epilepsy syndrome	4.75e-05	0.000352	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	4.74e-05	0.000351	CcSEcCtD
Nelfinavir—Asthenia—Carbamazepine—epilepsy syndrome	4.73e-05	0.00035	CcSEcCtD
Nelfinavir—Agitation—Gabapentin—epilepsy syndrome	4.73e-05	0.00035	CcSEcCtD
Nelfinavir—Diarrhoea—Phenytoin—epilepsy syndrome	4.72e-05	0.00035	CcSEcCtD
Nelfinavir—Discomfort—Pregabalin—epilepsy syndrome	4.72e-05	0.00035	CcSEcCtD
Nelfinavir—Nausea—Fosphenytoin—epilepsy syndrome	4.71e-05	0.000349	CcSEcCtD
Nelfinavir—Diarrhoea—Oxcarbazepine—epilepsy syndrome	4.7e-05	0.000348	CcSEcCtD
Nelfinavir—Erythema multiforme—Topiramate—epilepsy syndrome	4.7e-05	0.000348	CcSEcCtD
Nelfinavir—Hypersensitivity—Lamotrigine—epilepsy syndrome	4.69e-05	0.000348	CcSEcCtD
Nelfinavir—Vomiting—Felbamate—epilepsy syndrome	4.69e-05	0.000347	CcSEcCtD
Nelfinavir—Pruritus—Carbamazepine—epilepsy syndrome	4.66e-05	0.000346	CcSEcCtD
Nelfinavir—Rash—Felbamate—epilepsy syndrome	4.65e-05	0.000344	CcSEcCtD
Nelfinavir—Eye disorder—Topiramate—epilepsy syndrome	4.64e-05	0.000344	CcSEcCtD
Nelfinavir—Dermatitis—Felbamate—epilepsy syndrome	4.64e-05	0.000344	CcSEcCtD
Nelfinavir—Malaise—Gabapentin—epilepsy syndrome	4.64e-05	0.000344	CcSEcCtD
Nelfinavir—Headache—Felbamate—epilepsy syndrome	4.62e-05	0.000342	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	4.61e-05	0.000342	CcSEcCtD
Nelfinavir—Leukopenia—Gabapentin—epilepsy syndrome	4.6e-05	0.000341	CcSEcCtD
Nelfinavir—Dizziness—Clonazepam—epilepsy syndrome	4.6e-05	0.000341	CcSEcCtD
Nelfinavir—Nausea—Vigabatrin—epilepsy syndrome	4.59e-05	0.00034	CcSEcCtD
Nelfinavir—Vomiting—Zonisamide—epilepsy syndrome	4.59e-05	0.00034	CcSEcCtD
Nelfinavir—Insomnia—Valproic Acid—epilepsy syndrome	4.58e-05	0.000339	CcSEcCtD
Nelfinavir—Oedema—Pregabalin—epilepsy syndrome	4.58e-05	0.000339	CcSEcCtD
Nelfinavir—Asthenia—Lamotrigine—epilepsy syndrome	4.57e-05	0.000339	CcSEcCtD
Nelfinavir—Dizziness—Phenytoin—epilepsy syndrome	4.57e-05	0.000338	CcSEcCtD
Nelfinavir—Rash—Zonisamide—epilepsy syndrome	4.55e-05	0.000337	CcSEcCtD
Nelfinavir—Paraesthesia—Valproic Acid—epilepsy syndrome	4.55e-05	0.000337	CcSEcCtD
Nelfinavir—Dermatitis—Zonisamide—epilepsy syndrome	4.54e-05	0.000337	CcSEcCtD
Nelfinavir—Dizziness—Oxcarbazepine—epilepsy syndrome	4.54e-05	0.000337	CcSEcCtD
Nelfinavir—Nausea—Diazepam—epilepsy syndrome	4.52e-05	0.000335	CcSEcCtD
Nelfinavir—Headache—Zonisamide—epilepsy syndrome	4.52e-05	0.000335	CcSEcCtD
Nelfinavir—Dyspnoea—Valproic Acid—epilepsy syndrome	4.51e-05	0.000334	CcSEcCtD
Nelfinavir—Diarrhoea—Carbamazepine—epilepsy syndrome	4.51e-05	0.000334	CcSEcCtD
Nelfinavir—Angiopathy—Topiramate—epilepsy syndrome	4.51e-05	0.000334	CcSEcCtD
Nelfinavir—Pruritus—Lamotrigine—epilepsy syndrome	4.51e-05	0.000334	CcSEcCtD
Nelfinavir—Somnolence—Valproic Acid—epilepsy syndrome	4.5e-05	0.000333	CcSEcCtD
Nelfinavir—SLC22A1—forebrain—epilepsy syndrome	4.49e-05	0.0449	CbGeAlD
Nelfinavir—Immune system disorder—Topiramate—epilepsy syndrome	4.49e-05	0.000333	CcSEcCtD
Nelfinavir—Thrombocytopenia—Pregabalin—epilepsy syndrome	4.48e-05	0.000332	CcSEcCtD
Nelfinavir—Dyspepsia—Valproic Acid—epilepsy syndrome	4.46e-05	0.00033	CcSEcCtD
Nelfinavir—Convulsion—Gabapentin—epilepsy syndrome	4.46e-05	0.00033	CcSEcCtD
Nelfinavir—Skin disorder—Pregabalin—epilepsy syndrome	4.45e-05	0.000329	CcSEcCtD
Nelfinavir—Hyperhidrosis—Pregabalin—epilepsy syndrome	4.42e-05	0.000328	CcSEcCtD
Nelfinavir—Vomiting—Clonazepam—epilepsy syndrome	4.42e-05	0.000328	CcSEcCtD
Nelfinavir—Decreased appetite—Valproic Acid—epilepsy syndrome	4.4e-05	0.000326	CcSEcCtD
Nelfinavir—Vomiting—Phenytoin—epilepsy syndrome	4.39e-05	0.000325	CcSEcCtD
Nelfinavir—Rash—Clonazepam—epilepsy syndrome	4.38e-05	0.000325	CcSEcCtD
Nelfinavir—Dermatitis—Clonazepam—epilepsy syndrome	4.38e-05	0.000324	CcSEcCtD
Nelfinavir—Arthralgia—Gabapentin—epilepsy syndrome	4.38e-05	0.000324	CcSEcCtD
Nelfinavir—Myalgia—Gabapentin—epilepsy syndrome	4.38e-05	0.000324	CcSEcCtD
Nelfinavir—Nausea—Felbamate—epilepsy syndrome	4.38e-05	0.000324	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	4.37e-05	0.000324	CcSEcCtD
Nelfinavir—Vomiting—Oxcarbazepine—epilepsy syndrome	4.37e-05	0.000324	CcSEcCtD
Nelfinavir—Anxiety—Gabapentin—epilepsy syndrome	4.36e-05	0.000323	CcSEcCtD
Nelfinavir—Anorexia—Pregabalin—epilepsy syndrome	4.36e-05	0.000323	CcSEcCtD
Nelfinavir—Dizziness—Carbamazepine—epilepsy syndrome	4.36e-05	0.000323	CcSEcCtD
Nelfinavir—Diarrhoea—Lamotrigine—epilepsy syndrome	4.36e-05	0.000323	CcSEcCtD
Nelfinavir—Headache—Clonazepam—epilepsy syndrome	4.36e-05	0.000323	CcSEcCtD
Nelfinavir—Rash—Phenytoin—epilepsy syndrome	4.35e-05	0.000323	CcSEcCtD
Nelfinavir—Dermatitis—Phenytoin—epilepsy syndrome	4.35e-05	0.000322	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	4.35e-05	0.000322	CcSEcCtD
Nelfinavir—Rash—Oxcarbazepine—epilepsy syndrome	4.33e-05	0.000321	CcSEcCtD
Nelfinavir—Pain—Valproic Acid—epilepsy syndrome	4.33e-05	0.000321	CcSEcCtD
Nelfinavir—Dermatitis—Oxcarbazepine—epilepsy syndrome	4.33e-05	0.000321	CcSEcCtD
Nelfinavir—SLCO1A2—forebrain—epilepsy syndrome	4.33e-05	0.0432	CbGeAlD
Nelfinavir—Headache—Phenytoin—epilepsy syndrome	4.33e-05	0.000321	CcSEcCtD
Nelfinavir—Malnutrition—Topiramate—epilepsy syndrome	4.33e-05	0.000321	CcSEcCtD
Nelfinavir—Erythema—Topiramate—epilepsy syndrome	4.33e-05	0.000321	CcSEcCtD
Nelfinavir—Discomfort—Gabapentin—epilepsy syndrome	4.33e-05	0.00032	CcSEcCtD
Nelfinavir—Headache—Oxcarbazepine—epilepsy syndrome	4.3e-05	0.000319	CcSEcCtD
Nelfinavir—Nausea—Zonisamide—epilepsy syndrome	4.28e-05	0.000317	CcSEcCtD
Nelfinavir—Flatulence—Topiramate—epilepsy syndrome	4.26e-05	0.000316	CcSEcCtD
Nelfinavir—Dizziness—Lamotrigine—epilepsy syndrome	4.21e-05	0.000312	CcSEcCtD
Nelfinavir—Oedema—Gabapentin—epilepsy syndrome	4.2e-05	0.000311	CcSEcCtD
Nelfinavir—Vomiting—Carbamazepine—epilepsy syndrome	4.19e-05	0.000311	CcSEcCtD
Nelfinavir—Back pain—Topiramate—epilepsy syndrome	4.18e-05	0.00031	CcSEcCtD
Nelfinavir—Feeling abnormal—Valproic Acid—epilepsy syndrome	4.17e-05	0.000309	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	4.17e-05	0.000309	CcSEcCtD
Nelfinavir—Muscle spasms—Topiramate—epilepsy syndrome	4.16e-05	0.000308	CcSEcCtD
Nelfinavir—Rash—Carbamazepine—epilepsy syndrome	4.16e-05	0.000308	CcSEcCtD
Nelfinavir—Dermatitis—Carbamazepine—epilepsy syndrome	4.15e-05	0.000308	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	4.14e-05	0.000307	CcSEcCtD
Nelfinavir—Insomnia—Pregabalin—epilepsy syndrome	4.14e-05	0.000307	CcSEcCtD
Nelfinavir—SLC22A1—telencephalon—epilepsy syndrome	4.13e-05	0.0413	CbGeAlD
Nelfinavir—Nausea—Clonazepam—epilepsy syndrome	4.13e-05	0.000306	CcSEcCtD
Nelfinavir—Headache—Carbamazepine—epilepsy syndrome	4.13e-05	0.000306	CcSEcCtD
Nelfinavir—Paraesthesia—Pregabalin—epilepsy syndrome	4.11e-05	0.000305	CcSEcCtD
Nelfinavir—Thrombocytopenia—Gabapentin—epilepsy syndrome	4.11e-05	0.000304	CcSEcCtD
Nelfinavir—Nausea—Phenytoin—epilepsy syndrome	4.1e-05	0.000304	CcSEcCtD
Nelfinavir—Dyspnoea—Pregabalin—epilepsy syndrome	4.08e-05	0.000302	CcSEcCtD
Nelfinavir—Nausea—Oxcarbazepine—epilepsy syndrome	4.08e-05	0.000302	CcSEcCtD
Nelfinavir—Skin disorder—Gabapentin—epilepsy syndrome	4.08e-05	0.000302	CcSEcCtD
Nelfinavir—Somnolence—Pregabalin—epilepsy syndrome	4.07e-05	0.000301	CcSEcCtD
Nelfinavir—Hyperhidrosis—Gabapentin—epilepsy syndrome	4.06e-05	0.000301	CcSEcCtD
Nelfinavir—Vomiting—Lamotrigine—epilepsy syndrome	4.05e-05	0.0003	CcSEcCtD
Nelfinavir—Urticaria—Valproic Acid—epilepsy syndrome	4.02e-05	0.000298	CcSEcCtD
Nelfinavir—Rash—Lamotrigine—epilepsy syndrome	4.02e-05	0.000298	CcSEcCtD
Nelfinavir—Ill-defined disorder—Topiramate—epilepsy syndrome	4.01e-05	0.000297	CcSEcCtD
Nelfinavir—Dermatitis—Lamotrigine—epilepsy syndrome	4.01e-05	0.000297	CcSEcCtD
Nelfinavir—Abdominal pain—Valproic Acid—epilepsy syndrome	4e-05	0.000297	CcSEcCtD
Nelfinavir—Body temperature increased—Valproic Acid—epilepsy syndrome	4e-05	0.000297	CcSEcCtD
Nelfinavir—Anorexia—Gabapentin—epilepsy syndrome	4e-05	0.000296	CcSEcCtD
Nelfinavir—Anaemia—Topiramate—epilepsy syndrome	4e-05	0.000296	CcSEcCtD
Nelfinavir—Headache—Lamotrigine—epilepsy syndrome	3.99e-05	0.000296	CcSEcCtD
Nelfinavir—SLCO1A2—telencephalon—epilepsy syndrome	3.98e-05	0.0398	CbGeAlD
Nelfinavir—Decreased appetite—Pregabalin—epilepsy syndrome	3.98e-05	0.000295	CcSEcCtD
Nelfinavir—Agitation—Topiramate—epilepsy syndrome	3.98e-05	0.000295	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	3.95e-05	0.000293	CcSEcCtD
Nelfinavir—Nausea—Carbamazepine—epilepsy syndrome	3.92e-05	0.00029	CcSEcCtD
Nelfinavir—Pain—Pregabalin—epilepsy syndrome	3.91e-05	0.00029	CcSEcCtD
Nelfinavir—Malaise—Topiramate—epilepsy syndrome	3.9e-05	0.000289	CcSEcCtD
Nelfinavir—Leukopenia—Topiramate—epilepsy syndrome	3.87e-05	0.000287	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	3.82e-05	0.000283	CcSEcCtD
Nelfinavir—Insomnia—Gabapentin—epilepsy syndrome	3.8e-05	0.000281	CcSEcCtD
Nelfinavir—Nausea—Lamotrigine—epilepsy syndrome	3.78e-05	0.00028	CcSEcCtD
Nelfinavir—Feeling abnormal—Pregabalin—epilepsy syndrome	3.77e-05	0.000279	CcSEcCtD
Nelfinavir—Paraesthesia—Gabapentin—epilepsy syndrome	3.77e-05	0.000279	CcSEcCtD
Nelfinavir—Convulsion—Topiramate—epilepsy syndrome	3.75e-05	0.000278	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Pregabalin—epilepsy syndrome	3.74e-05	0.000277	CcSEcCtD
Nelfinavir—Dyspnoea—Gabapentin—epilepsy syndrome	3.74e-05	0.000277	CcSEcCtD
Nelfinavir—Somnolence—Gabapentin—epilepsy syndrome	3.73e-05	0.000276	CcSEcCtD
Nelfinavir—Hypersensitivity—Valproic Acid—epilepsy syndrome	3.73e-05	0.000276	CcSEcCtD
Nelfinavir—Dyspepsia—Gabapentin—epilepsy syndrome	3.69e-05	0.000274	CcSEcCtD
Nelfinavir—Arthralgia—Topiramate—epilepsy syndrome	3.68e-05	0.000273	CcSEcCtD
Nelfinavir—Myalgia—Topiramate—epilepsy syndrome	3.68e-05	0.000273	CcSEcCtD
Nelfinavir—Anxiety—Topiramate—epilepsy syndrome	3.67e-05	0.000272	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	3.66e-05	0.000271	CcSEcCtD
Nelfinavir—Decreased appetite—Gabapentin—epilepsy syndrome	3.65e-05	0.00027	CcSEcCtD
Nelfinavir—CYP2D6—hindbrain—epilepsy syndrome	3.64e-05	0.0364	CbGeAlD
Nelfinavir—Discomfort—Topiramate—epilepsy syndrome	3.64e-05	0.00027	CcSEcCtD
Nelfinavir—Urticaria—Pregabalin—epilepsy syndrome	3.64e-05	0.000269	CcSEcCtD
Nelfinavir—Asthenia—Valproic Acid—epilepsy syndrome	3.63e-05	0.000269	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	3.62e-05	0.000268	CcSEcCtD
Nelfinavir—Abdominal pain—Pregabalin—epilepsy syndrome	3.62e-05	0.000268	CcSEcCtD
Nelfinavir—Body temperature increased—Pregabalin—epilepsy syndrome	3.62e-05	0.000268	CcSEcCtD
Nelfinavir—Pain—Gabapentin—epilepsy syndrome	3.59e-05	0.000266	CcSEcCtD
Nelfinavir—Pruritus—Valproic Acid—epilepsy syndrome	3.58e-05	0.000265	CcSEcCtD
Nelfinavir—Oedema—Topiramate—epilepsy syndrome	3.53e-05	0.000262	CcSEcCtD
Nelfinavir—Diarrhoea—Valproic Acid—epilepsy syndrome	3.46e-05	0.000257	CcSEcCtD
Nelfinavir—Feeling abnormal—Gabapentin—epilepsy syndrome	3.46e-05	0.000256	CcSEcCtD
Nelfinavir—Thrombocytopenia—Topiramate—epilepsy syndrome	3.46e-05	0.000256	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Gabapentin—epilepsy syndrome	3.43e-05	0.000254	CcSEcCtD
Nelfinavir—Skin disorder—Topiramate—epilepsy syndrome	3.43e-05	0.000254	CcSEcCtD
Nelfinavir—Hyperhidrosis—Topiramate—epilepsy syndrome	3.41e-05	0.000253	CcSEcCtD
Nelfinavir—Hypersensitivity—Pregabalin—epilepsy syndrome	3.37e-05	0.00025	CcSEcCtD
Nelfinavir—Anorexia—Topiramate—epilepsy syndrome	3.37e-05	0.000249	CcSEcCtD
Nelfinavir—Dizziness—Valproic Acid—epilepsy syndrome	3.35e-05	0.000248	CcSEcCtD
Nelfinavir—Urticaria—Gabapentin—epilepsy syndrome	3.33e-05	0.000247	CcSEcCtD
Nelfinavir—Body temperature increased—Gabapentin—epilepsy syndrome	3.32e-05	0.000246	CcSEcCtD
Nelfinavir—Abdominal pain—Gabapentin—epilepsy syndrome	3.32e-05	0.000246	CcSEcCtD
Nelfinavir—Asthenia—Pregabalin—epilepsy syndrome	3.28e-05	0.000243	CcSEcCtD
Nelfinavir—Pruritus—Pregabalin—epilepsy syndrome	3.24e-05	0.00024	CcSEcCtD
Nelfinavir—Vomiting—Valproic Acid—epilepsy syndrome	3.22e-05	0.000238	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	3.22e-05	0.000238	CcSEcCtD
Nelfinavir—Insomnia—Topiramate—epilepsy syndrome	3.19e-05	0.000237	CcSEcCtD
Nelfinavir—Rash—Valproic Acid—epilepsy syndrome	3.19e-05	0.000237	CcSEcCtD
Nelfinavir—Dermatitis—Valproic Acid—epilepsy syndrome	3.19e-05	0.000236	CcSEcCtD
Nelfinavir—Headache—Valproic Acid—epilepsy syndrome	3.17e-05	0.000235	CcSEcCtD
Nelfinavir—Paraesthesia—Topiramate—epilepsy syndrome	3.17e-05	0.000235	CcSEcCtD
Nelfinavir—Dyspnoea—Topiramate—epilepsy syndrome	3.15e-05	0.000233	CcSEcCtD
Nelfinavir—Somnolence—Topiramate—epilepsy syndrome	3.14e-05	0.000233	CcSEcCtD
Nelfinavir—Diarrhoea—Pregabalin—epilepsy syndrome	3.13e-05	0.000232	CcSEcCtD
Nelfinavir—SLCO1A2—medulla oblongata—epilepsy syndrome	3.13e-05	0.0312	CbGeAlD
Nelfinavir—Dyspepsia—Topiramate—epilepsy syndrome	3.11e-05	0.00023	CcSEcCtD
Nelfinavir—Hypersensitivity—Gabapentin—epilepsy syndrome	3.09e-05	0.000229	CcSEcCtD
Nelfinavir—Decreased appetite—Topiramate—epilepsy syndrome	3.07e-05	0.000227	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Topiramate—epilepsy syndrome	3.05e-05	0.000226	CcSEcCtD
Nelfinavir—Dizziness—Pregabalin—epilepsy syndrome	3.03e-05	0.000224	CcSEcCtD
Nelfinavir—Pain—Topiramate—epilepsy syndrome	3.02e-05	0.000224	CcSEcCtD
Nelfinavir—Asthenia—Gabapentin—epilepsy syndrome	3.01e-05	0.000223	CcSEcCtD
Nelfinavir—Nausea—Valproic Acid—epilepsy syndrome	3.01e-05	0.000223	CcSEcCtD
Nelfinavir—Pruritus—Gabapentin—epilepsy syndrome	2.97e-05	0.00022	CcSEcCtD
Nelfinavir—Vomiting—Pregabalin—epilepsy syndrome	2.91e-05	0.000216	CcSEcCtD
Nelfinavir—Feeling abnormal—Topiramate—epilepsy syndrome	2.91e-05	0.000216	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.89e-05	0.000214	CcSEcCtD
Nelfinavir—Rash—Pregabalin—epilepsy syndrome	2.89e-05	0.000214	CcSEcCtD
Nelfinavir—Dermatitis—Pregabalin—epilepsy syndrome	2.88e-05	0.000214	CcSEcCtD
Nelfinavir—Diarrhoea—Gabapentin—epilepsy syndrome	2.87e-05	0.000213	CcSEcCtD
Nelfinavir—Headache—Pregabalin—epilepsy syndrome	2.87e-05	0.000212	CcSEcCtD
Nelfinavir—SLCO1A2—midbrain—epilepsy syndrome	2.86e-05	0.0286	CbGeAlD
Nelfinavir—Urticaria—Topiramate—epilepsy syndrome	2.8e-05	0.000208	CcSEcCtD
Nelfinavir—Abdominal pain—Topiramate—epilepsy syndrome	2.79e-05	0.000207	CcSEcCtD
Nelfinavir—Body temperature increased—Topiramate—epilepsy syndrome	2.79e-05	0.000207	CcSEcCtD
Nelfinavir—SLCO1A2—spinal cord—epilepsy syndrome	2.79e-05	0.0279	CbGeAlD
Nelfinavir—Dizziness—Gabapentin—epilepsy syndrome	2.78e-05	0.000206	CcSEcCtD
Nelfinavir—Nausea—Pregabalin—epilepsy syndrome	2.72e-05	0.000201	CcSEcCtD
Nelfinavir—ABCG2—telencephalon—epilepsy syndrome	2.7e-05	0.027	CbGeAlD
Nelfinavir—Vomiting—Gabapentin—epilepsy syndrome	2.67e-05	0.000198	CcSEcCtD
Nelfinavir—Rash—Gabapentin—epilepsy syndrome	2.65e-05	0.000196	CcSEcCtD
Nelfinavir—Dermatitis—Gabapentin—epilepsy syndrome	2.64e-05	0.000196	CcSEcCtD
Nelfinavir—Headache—Gabapentin—epilepsy syndrome	2.63e-05	0.000195	CcSEcCtD
Nelfinavir—Hypersensitivity—Topiramate—epilepsy syndrome	2.6e-05	0.000193	CcSEcCtD
Nelfinavir—SLC22A1—head—epilepsy syndrome	2.57e-05	0.0257	CbGeAlD
Nelfinavir—Asthenia—Topiramate—epilepsy syndrome	2.53e-05	0.000188	CcSEcCtD
Nelfinavir—Pruritus—Topiramate—epilepsy syndrome	2.5e-05	0.000185	CcSEcCtD
Nelfinavir—Nausea—Gabapentin—epilepsy syndrome	2.49e-05	0.000185	CcSEcCtD
Nelfinavir—SLCO1A2—head—epilepsy syndrome	2.48e-05	0.0248	CbGeAlD
Nelfinavir—SLC22A1—nervous system—epilepsy syndrome	2.44e-05	0.0244	CbGeAlD
Nelfinavir—Diarrhoea—Topiramate—epilepsy syndrome	2.42e-05	0.000179	CcSEcCtD
Nelfinavir—SLCO1A2—nervous system—epilepsy syndrome	2.35e-05	0.0235	CbGeAlD
Nelfinavir—SLC22A1—central nervous system—epilepsy syndrome	2.35e-05	0.0235	CbGeAlD
Nelfinavir—Dizziness—Topiramate—epilepsy syndrome	2.33e-05	0.000173	CcSEcCtD
Nelfinavir—SLCO1A2—central nervous system—epilepsy syndrome	2.26e-05	0.0226	CbGeAlD
Nelfinavir—Vomiting—Topiramate—epilepsy syndrome	2.24e-05	0.000166	CcSEcCtD
Nelfinavir—Rash—Topiramate—epilepsy syndrome	2.23e-05	0.000165	CcSEcCtD
Nelfinavir—Dermatitis—Topiramate—epilepsy syndrome	2.22e-05	0.000165	CcSEcCtD
Nelfinavir—Headache—Topiramate—epilepsy syndrome	2.21e-05	0.000164	CcSEcCtD
Nelfinavir—SLCO1A2—cerebellum—epilepsy syndrome	2.21e-05	0.0221	CbGeAlD
Nelfinavir—ABCG2—medulla oblongata—epilepsy syndrome	2.12e-05	0.0212	CbGeAlD
Nelfinavir—Nausea—Topiramate—epilepsy syndrome	2.1e-05	0.000155	CcSEcCtD
Nelfinavir—CYP2D6—brainstem—epilepsy syndrome	2.09e-05	0.0209	CbGeAlD
Nelfinavir—CYP2D6—forebrain—epilepsy syndrome	2.01e-05	0.0201	CbGeAlD
Nelfinavir—ABCG2—midbrain—epilepsy syndrome	1.94e-05	0.0194	CbGeAlD
Nelfinavir—ABCG2—spinal cord—epilepsy syndrome	1.89e-05	0.0189	CbGeAlD
Nelfinavir—SLC22A1—brain—epilepsy syndrome	1.86e-05	0.0186	CbGeAlD
Nelfinavir—CYP2D6—telencephalon—epilepsy syndrome	1.85e-05	0.0185	CbGeAlD
Nelfinavir—SLCO1A2—brain—epilepsy syndrome	1.8e-05	0.0179	CbGeAlD
Nelfinavir—CYP2B6—head—epilepsy syndrome	1.55e-05	0.0155	CbGeAlD
Nelfinavir—ABCG2—cerebellum—epilepsy syndrome	1.5e-05	0.015	CbGeAlD
Nelfinavir—CYP2B6—nervous system—epilepsy syndrome	1.47e-05	0.0147	CbGeAlD
Nelfinavir—ABCB1—forebrain—epilepsy syndrome	1.45e-05	0.0145	CbGeAlD
Nelfinavir—CYP2B6—central nervous system—epilepsy syndrome	1.42e-05	0.0142	CbGeAlD
Nelfinavir—ABCB1—telencephalon—epilepsy syndrome	1.33e-05	0.0133	CbGeAlD
Nelfinavir—ABCG2—brain—epilepsy syndrome	1.22e-05	0.0122	CbGeAlD
Nelfinavir—CYP2D6—head—epilepsy syndrome	1.15e-05	0.0115	CbGeAlD
Nelfinavir—CYP2B6—brain—epilepsy syndrome	1.13e-05	0.0112	CbGeAlD
Nelfinavir—CYP3A4—nervous system—epilepsy syndrome	1.11e-05	0.0111	CbGeAlD
Nelfinavir—CYP2D6—nervous system—epilepsy syndrome	1.09e-05	0.0109	CbGeAlD
Nelfinavir—CYP3A4—central nervous system—epilepsy syndrome	1.07e-05	0.0107	CbGeAlD
Nelfinavir—CYP2D6—central nervous system—epilepsy syndrome	1.05e-05	0.0105	CbGeAlD
Nelfinavir—ABCB1—medulla oblongata—epilepsy syndrome	1.05e-05	0.0105	CbGeAlD
Nelfinavir—CYP2D6—cerebellum—epilepsy syndrome	1.03e-05	0.0103	CbGeAlD
Nelfinavir—ABCB1—midbrain—epilepsy syndrome	9.57e-06	0.00957	CbGeAlD
Nelfinavir—ABCB1—spinal cord—epilepsy syndrome	9.34e-06	0.00933	CbGeAlD
Nelfinavir—CYP2D6—brain—epilepsy syndrome	8.36e-06	0.00836	CbGeAlD
Nelfinavir—ABCB1—head—epilepsy syndrome	8.3e-06	0.0083	CbGeAlD
Nelfinavir—ABCB1—nervous system—epilepsy syndrome	7.87e-06	0.00786	CbGeAlD
Nelfinavir—ABCB1—central nervous system—epilepsy syndrome	7.58e-06	0.00757	CbGeAlD
Nelfinavir—ABCB1—cerebellum—epilepsy syndrome	7.4e-06	0.0074	CbGeAlD
Nelfinavir—ABCB1—brain—epilepsy syndrome	6.01e-06	0.00601	CbGeAlD
Nelfinavir—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	4.29e-06	8.46e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	4.29e-06	8.46e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—CYP2C19—epilepsy syndrome	4.28e-06	8.46e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—CYP11A1—epilepsy syndrome	4.26e-06	8.41e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—CAT—epilepsy syndrome	4.25e-06	8.39e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—AQP1—epilepsy syndrome	4.24e-06	8.37e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—AQP1—epilepsy syndrome	4.2e-06	8.3e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	4.19e-06	8.28e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ATIC—epilepsy syndrome	4.18e-06	8.26e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—UPB1—epilepsy syndrome	4.18e-06	8.26e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—NEU1—epilepsy syndrome	4.18e-06	8.26e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	4.17e-06	8.23e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	4.17e-06	8.23e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—ABCB1—epilepsy syndrome	4.13e-06	8.17e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	4.11e-06	8.12e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—ADSL—epilepsy syndrome	4.11e-06	8.11e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	4.07e-06	8.03e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—CHRM3—epilepsy syndrome	4.07e-06	8.03e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	4.04e-06	7.97e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—GLUL—epilepsy syndrome	4.03e-06	7.96e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	4.03e-06	7.95e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—HMOX1—epilepsy syndrome	3.99e-06	7.88e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	3.95e-06	7.81e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—HMOX1—epilepsy syndrome	3.95e-06	7.81e-05	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—AGT—epilepsy syndrome	3.94e-06	7.78e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—CAT—epilepsy syndrome	3.94e-06	7.77e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—CYP2D6—epilepsy syndrome	3.93e-06	7.76e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—CAT—epilepsy syndrome	3.9e-06	7.7e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GBE1—epilepsy syndrome	3.89e-06	7.68e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	3.89e-06	7.68e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.88e-06	7.67e-05	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—APOE—epilepsy syndrome	3.86e-06	7.63e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—GPX1—epilepsy syndrome	3.84e-06	7.59e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—CYP2D6—epilepsy syndrome	3.84e-06	7.59e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	3.83e-06	7.57e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	3.83e-06	7.57e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—ABCB1—epilepsy syndrome	3.83e-06	7.56e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.8e-06	7.51e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	3.8e-06	7.51e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	3.8e-06	7.51e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—ABCB1—epilepsy syndrome	3.79e-06	7.49e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—ADRA2A—epilepsy syndrome	3.74e-06	7.39e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—BCHE—epilepsy syndrome	3.73e-06	7.36e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	3.7e-06	7.31e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—HMOX1—epilepsy syndrome	3.68e-06	7.27e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	3.66e-06	7.22e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—ADRA2A—epilepsy syndrome	3.66e-06	7.22e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—BCHE—epilepsy syndrome	3.64e-06	7.19e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—CAT—epilepsy syndrome	3.63e-06	7.17e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—AQP1—epilepsy syndrome	3.59e-06	7.09e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—GPX1—epilepsy syndrome	3.56e-06	7.03e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	3.56e-06	7.03e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—SLC2A1—epilepsy syndrome	3.55e-06	7.02e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.54e-06	6.99e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—ABCB1—epilepsy syndrome	3.53e-06	6.97e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—GPX1—epilepsy syndrome	3.53e-06	6.97e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PLCB1—epilepsy syndrome	3.52e-06	6.94e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—TH—epilepsy syndrome	3.5e-06	6.92e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—SLC2A1—epilepsy syndrome	3.47e-06	6.86e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.47e-06	6.85e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—NT5E—epilepsy syndrome	3.47e-06	6.85e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ALAD—epilepsy syndrome	3.47e-06	6.85e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	3.45e-06	6.81e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PLCB1—epilepsy syndrome	3.44e-06	6.79e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—TH—epilepsy syndrome	3.42e-06	6.76e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	3.4e-06	6.71e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—AGT—epilepsy syndrome	3.37e-06	6.66e-05	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—POMC—epilepsy syndrome	3.32e-06	6.55e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—ABCG2—epilepsy syndrome	3.32e-06	6.55e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	3.31e-06	6.53e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	3.31e-06	6.53e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—APOE—epilepsy syndrome	3.3e-06	6.52e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	3.29e-06	6.5e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—GPX1—epilepsy syndrome	3.28e-06	6.48e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.27e-06	6.45e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	3.25e-06	6.41e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	3.25e-06	6.41e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	3.24e-06	6.39e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	3.23e-06	6.38e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	3.21e-06	6.34e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ADSL—epilepsy syndrome	3.17e-06	6.26e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	3.13e-06	6.17e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—AGT—epilepsy syndrome	3.12e-06	6.16e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GLUL—epilepsy syndrome	3.11e-06	6.14e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	3.1e-06	6.12e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—AGT—epilepsy syndrome	3.09e-06	6.11e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	3.06e-06	6.05e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—APOE—epilepsy syndrome	3.06e-06	6.04e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	3.05e-06	6.03e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	3.05e-06	6.01e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—APOE—epilepsy syndrome	3.03e-06	5.99e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	3.03e-06	5.98e-05	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—ALB—epilepsy syndrome	3.02e-06	5.97e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.02e-06	5.97e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	3.02e-06	5.96e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	3e-06	5.93e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.98e-06	5.88e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.98e-06	5.88e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	2.97e-06	5.87e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.96e-06	5.85e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—HMOX1—epilepsy syndrome	2.92e-06	5.77e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	2.9e-06	5.73e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—CAT—epilepsy syndrome	2.88e-06	5.7e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—AGT—epilepsy syndrome	2.88e-06	5.69e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	2.86e-06	5.64e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	2.85e-06	5.64e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—POMC—epilepsy syndrome	2.84e-06	5.6e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	2.83e-06	5.58e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—APOE—epilepsy syndrome	2.82e-06	5.57e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—CAT—epilepsy syndrome	2.82e-06	5.57e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—BCHE—epilepsy syndrome	2.82e-06	5.56e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—ABCB1—epilepsy syndrome	2.81e-06	5.54e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—AQP1—epilepsy syndrome	2.77e-06	5.47e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.76e-06	5.46e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	2.76e-06	5.45e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—BCHE—epilepsy syndrome	2.75e-06	5.43e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	2.74e-06	5.42e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.72e-06	5.36e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	2.71e-06	5.35e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	2.69e-06	5.3e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	2.66e-06	5.25e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	2.65e-06	5.23e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—TH—epilepsy syndrome	2.65e-06	5.23e-05	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—PTGS2—epilepsy syndrome	2.65e-06	5.23e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—POMC—epilepsy syndrome	2.63e-06	5.19e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	2.62e-06	5.18e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—GPX1—epilepsy syndrome	2.61e-06	5.15e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.61e-06	5.15e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—POMC—epilepsy syndrome	2.6e-06	5.14e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	2.6e-06	5.14e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PLCB1—epilepsy syndrome	2.59e-06	5.12e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—BCHE—epilepsy syndrome	2.59e-06	5.11e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—ALB—epilepsy syndrome	2.59e-06	5.11e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—TH—epilepsy syndrome	2.58e-06	5.1e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	2.58e-06	5.1e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	2.58e-06	5.09e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—BCHE—epilepsy syndrome	2.57e-06	5.07e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	2.56e-06	5.06e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—GPX1—epilepsy syndrome	2.55e-06	5.04e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.55e-06	5.03e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	2.51e-06	4.95e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	2.51e-06	4.95e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	2.47e-06	4.88e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	2.45e-06	4.84e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	2.44e-06	4.83e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—TH—epilepsy syndrome	2.43e-06	4.81e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—POMC—epilepsy syndrome	2.42e-06	4.79e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	2.42e-06	4.78e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—TH—epilepsy syndrome	2.41e-06	4.77e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—ALB—epilepsy syndrome	2.39e-06	4.73e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.38e-06	4.69e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—ALB—epilepsy syndrome	2.37e-06	4.69e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.32e-06	4.58e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	2.31e-06	4.57e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—AGT—epilepsy syndrome	2.29e-06	4.52e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PTGS2—epilepsy syndrome	2.26e-06	4.47e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—APOE—epilepsy syndrome	2.24e-06	4.43e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—AGT—epilepsy syndrome	2.24e-06	4.42e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	2.21e-06	4.36e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—ALB—epilepsy syndrome	2.21e-06	4.36e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	2.2e-06	4.35e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—BCHE—epilepsy syndrome	2.19e-06	4.33e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—APOE—epilepsy syndrome	2.19e-06	4.33e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—CAT—epilepsy syndrome	2.18e-06	4.31e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—HMOX1—epilepsy syndrome	2.16e-06	4.26e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—CAT—epilepsy syndrome	2.13e-06	4.2e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	2.12e-06	4.19e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PTGS2—epilepsy syndrome	2.1e-06	4.14e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	2.09e-06	4.13e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PTGS2—epilepsy syndrome	2.08e-06	4.1e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	2.07e-06	4.09e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—TH—epilepsy syndrome	2.06e-06	4.07e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	2.04e-06	4.04e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	2.03e-06	4.01e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.03e-06	4.01e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	2.01e-06	3.98e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CAT—epilepsy syndrome	2e-06	3.96e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.99e-06	3.93e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CAT—epilepsy syndrome	1.99e-06	3.93e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.98e-06	3.91e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—GPX1—epilepsy syndrome	1.97e-06	3.89e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	1.95e-06	3.85e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	1.93e-06	3.82e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PTGS2—epilepsy syndrome	1.93e-06	3.82e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—POMC—epilepsy syndrome	1.93e-06	3.8e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—GPX1—epilepsy syndrome	1.92e-06	3.8e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—POMC—epilepsy syndrome	1.88e-06	3.72e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—GPX1—epilepsy syndrome	1.81e-06	3.58e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—GPX1—epilepsy syndrome	1.8e-06	3.55e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.79e-06	3.53e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—ALB—epilepsy syndrome	1.76e-06	3.47e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—AGT—epilepsy syndrome	1.73e-06	3.41e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	1.72e-06	3.4e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—ALB—epilepsy syndrome	1.72e-06	3.39e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.7e-06	3.36e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CAT—epilepsy syndrome	1.7e-06	3.35e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—APOE—epilepsy syndrome	1.69e-06	3.35e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.69e-06	3.34e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—AGT—epilepsy syndrome	1.69e-06	3.33e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—APOE—epilepsy syndrome	1.65e-06	3.27e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	1.65e-06	3.26e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.62e-06	3.19e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.6e-06	3.16e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—TH—epilepsy syndrome	1.59e-06	3.14e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—AGT—epilepsy syndrome	1.59e-06	3.14e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—AGT—epilepsy syndrome	1.58e-06	3.11e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—APOE—epilepsy syndrome	1.56e-06	3.08e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—APOE—epilepsy syndrome	1.54e-06	3.05e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—GPX1—epilepsy syndrome	1.54e-06	3.03e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PTGS2—epilepsy syndrome	1.54e-06	3.03e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	1.5e-06	2.96e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—POMC—epilepsy syndrome	1.46e-06	2.87e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—POMC—epilepsy syndrome	1.42e-06	2.8e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—AGT—epilepsy syndrome	1.35e-06	2.66e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—POMC—epilepsy syndrome	1.34e-06	2.64e-05	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—AKT1—epilepsy syndrome	1.33e-06	2.63e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.33e-06	2.62e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—POMC—epilepsy syndrome	1.33e-06	2.62e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—ALB—epilepsy syndrome	1.33e-06	2.62e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—APOE—epilepsy syndrome	1.32e-06	2.61e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.31e-06	2.59e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—ALB—epilepsy syndrome	1.29e-06	2.56e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.28e-06	2.52e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—ALB—epilepsy syndrome	1.22e-06	2.41e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—ALB—epilepsy syndrome	1.21e-06	2.39e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.19e-06	2.34e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	1.16e-06	2.29e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—AKT1—epilepsy syndrome	1.14e-06	2.25e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—POMC—epilepsy syndrome	1.13e-06	2.24e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PTGS2—epilepsy syndrome	1.13e-06	2.24e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	1.07e-06	2.11e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	1.06e-06	2.09e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—AKT1—epilepsy syndrome	1.05e-06	2.08e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—AKT1—epilepsy syndrome	1.04e-06	2.06e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.04e-06	2.05e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—ALB—epilepsy syndrome	1.03e-06	2.04e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.02e-06	2.01e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—AKT1—epilepsy syndrome	9.71e-07	1.92e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	9.04e-07	1.79e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—POMC—epilepsy syndrome	8.75e-07	1.73e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ALB—epilepsy syndrome	7.98e-07	1.58e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—AKT1—epilepsy syndrome	7.72e-07	1.52e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—AKT1—epilepsy syndrome	7.54e-07	1.49e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	6.98e-07	1.38e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—AKT1—epilepsy syndrome	5.83e-07	1.15e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—AKT1—epilepsy syndrome	5.69e-07	1.12e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—AKT1—epilepsy syndrome	5.36e-07	1.06e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—AKT1—epilepsy syndrome	5.32e-07	1.05e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—AKT1—epilepsy syndrome	4.54e-07	8.98e-06	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—AKT1—epilepsy syndrome	3.51e-07	6.93e-06	CbGpPWpGaD
